We are Sorry, This Page doesn't Exist
Paratek Pharmaceuticals announces first patient dosed in omadacycline study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aveo Pharmaceuticals" ph3 study of FOTIVDA saw higher durability of response
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
CNS Pharmaceuticals begins patient enrollment in Berubicin study for GBM
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Paratek Pharmaceuticals reports Q1 EPS (39c), consensus (38c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
The Yankees" "breakthrough" COVID-19 infections are a case study in how the virus can spread among vaccinated people
The Yankees' relaxed restr.....»»
Diffusion Pharmaceuticals reports results from Phase 1b study of TSC
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aurinia Pharmaceuticals: AURORA 1 Phase 3 study results published in The Lancet
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Phathom Pharmaceuticals jumps 8% to $43 after study meets endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
TerraVest And TVA: Investment Case Study – Guy Gottfried
A presentation on TVA Group Inc (TSE:TVA.B) (OTCMKTS:TVAGF) and TerraVest Industries Inc (TSE:TVK) (OTCMKTS:TRRVF), that Guy Gottfried gave at the Ben Graham Centre’s 2021 Virtual Value Investing Conference. Download the PDF of the presentation here. .....»»
Vertex to study experimental gene-editing therapy as treatment for sickle cell, beta-thalassemia
Vertex Pharmaceuticals Inc. said Tuesday it plans to pay $1.1 billion to Crispr Therapeutics AG as part of a deal to test an experimental gene-editing therapy for sickle cell disease and transfusion-dependent beta-tha.....»»
Corbus Pharmaceuticals completes enrollment in Phase 2 study of Lenabasum
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ionis Pharmaceuticals initiates pivotal clinical study of ION373
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
: Getting COVID creates far higher risk of rare blood clots than vaccines, Oxford study finds
A new study from researchers at Oxford University has found that people who contract COVID-19 are at far higher risk of developing blood clots than people who receive COVID-19 vaccines, further bolstering the case for vaccine use......»»
Corbus Pharmaceuticals reports last subject visit in Determine phase 3 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Milestone Pharmaceuticals announces first patient enrolled in ReVeRA study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ionis Pharma"s Ligand-Conjugated Antisense Hits Primary Endpoint Goal In Hereditary Angioedema Study
Ionis Pharmaceuticals Inc (NASDAQ: IONS) has read more.....»»
Ionis Pharmaceuticals: Phase 2 study of IONIS-PKK-L met endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
CytoDyn: Case study of COVID patient treated with leronlimab published in JTA
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Why this Albany IT company is going fully remote and rethinking its office space
"We wanted to be leading from the front on this and be a case study for consultants to point back to us,” said Christopher Luise, co-CEO of ADNET Technologies......»»